Page last updated: 2024-09-04

levofloxacin and Disbacteriosis

levofloxacin has been researched along with Disbacteriosis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Alvarado-Jáquez, MF; Bernal-Alferes, BJ; Burgos-Vargas, R; Chaparro-Barrera, E; Cuevas-Martínez, R; Espino-Solís, GP; González-Chávez, SA; López-Loeza, SM; Marín-Terrazas, C; Orrantia-Borunda, E; Pacheco-Tena, C; Romero-López, JP; Salas-Leiva, DE; Salas-Leiva, JS; Sausameda-García, J; Torres-Quintana, M1
Cao, Y; Chen, J; Han, Y; Liang, X; Song, M; Xiao, H; Xiao, J; Yang, X; Zhan, M; Zhao, C1
Andremont, A; Burdet, C; Corbel, T; de Gunzburg, J; Ferreira, S; Mentré, F; Nevière, A; Pulse, M; Sablier-Gallis, F; Saint-Lu, N; Sayah-Jeanne, S; Weiss, W1
Holtan, SG; Kaiser, T; Khoruts, A; Rashidi, A; Rehman, TU; Staley, C; Weisdorf, DJ1

Other Studies

4 other study(ies) available for levofloxacin and Disbacteriosis

ArticleYear
Levofloxacin induces differential effects in the transcriptome between the gut, peripheral and axial joints in the Spondyloarthritis DBA/1 mice: Improvement of intestinal dysbiosis and the overall inflammatory process.
    PloS one, 2023, Volume: 18, Issue:2

    Topics: Animals; Dysbiosis; Inflammation; Levofloxacin; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; RNA, Ribosomal, 16S; Spondylarthritis; Transcriptome; Tumor Necrosis Factor-alpha

2023
Dietary 5-demethylnobiletin prevents antibiotic-associated dysbiosis of gut microbiota and damage to the colonic barrier.
    Food & function, 2023, May-11, Volume: 14, Issue:9

    Topics: Animals; Anti-Bacterial Agents; Bacteria; Butyric Acid; Cefuroxime; Colon; Dysbiosis; Gastrointestinal Microbiome; Intestinal Diseases; Intestines; Levofloxacin; Mice

2023
DAV131A Protects Hamsters from Lethal
    Antimicrobial agents and chemotherapy, 2019, 12-20, Volume: 64, Issue:1

    Topics: Administration, Oral; Adsorption; Animals; Anti-Bacterial Agents; Charcoal; Ciprofloxacin; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Dysbiosis; Fluoroquinolones; Gastrointestinal Microbiome; Levofloxacin; Male; Mesocricetus

2019
Levaquin Gets a Pass.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2020, Volume: 26, Issue:4

    Topics: Dysbiosis; Gastrointestinal Microbiome; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; RNA, Ribosomal, 16S

2020